{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:07:09Z","timestamp":1790842029898,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.omtm.2022.08.009","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T02:57:24Z","timestamp":1662087444000},"page":"47-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["A first-in-human phase I\/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6440-3376","authenticated-orcid":false,"given":"Kevin M.","family":"Flanigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-9140","authenticated-orcid":false,"given":"Tatyana A.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabatha R.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2800-3855","authenticated-orcid":false,"given":"Megan","family":"Iammarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0360-6502","authenticated-orcid":false,"given":"Emma C.","family":"Frair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis G.","family":"Chicoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9616-4899","authenticated-orcid":false,"given":"Johan","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Cheatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5099-2376","authenticated-orcid":false,"given":"Sharon L.","family":"Cheatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7300-995X","authenticated-orcid":false,"given":"Brian","family":"Boe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9621-8319","authenticated-orcid":false,"given":"Megan A.","family":"Waldrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Zygmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3027-3758","authenticated-orcid":false,"given":"Davin","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0674-6191","authenticated-orcid":false,"given":"Paul T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2022.08.009_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2022.08.009_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtm.2022.08.009_bib3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1177\/0883073810371004","article-title":"Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management","volume":"25","author":"Moxley","year":"2010","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.omtm.2022.08.009_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0960-8966(02)00136-0","article-title":"Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases Newcastle, January 2002","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2022.08.009_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy","volume":"79","author":"Mendell","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2022.08.009_bib6","doi-asserted-by":"crossref","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","article-title":"Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy","volume":"94","author":"Frank","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2022.08.009_bib7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamaneurol.2020.1264","article-title":"Safety, tolerability, and efficacy of Viltolarsen in boys with Duchenne muscular dystrophy amenable to exon 53 skipping: a phase 2 Randomized clinical trial","volume":"77","author":"Clemens","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.omtm.2022.08.009_bib8","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.08.009_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of systemic delivery of rAAVrh74.MHCK7.micro-dystrophin in Children with Duchenne muscular dystrophy: a nonrandomized controlled trial","author":"Mendell","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.omtm.2022.08.009_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/mt.2013.244","article-title":"Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.08.009_bib11","doi-asserted-by":"crossref","first-page":"C476","DOI":"10.1152\/ajpcell.00456.2008","article-title":"Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice","volume":"296","author":"Martin","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omtm.2022.08.009_bib12","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.082613599","article-title":"Overexpression of the cytotoxic T\u00a0cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice","volume":"99","author":"Nguyen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2022.08.009_bib13","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ajpath.2016.05.021","article-title":"B4GALNT2 (GALGT2) gene therapy reduces skeletal muscle pathology in the FKRP P448L mouse model of limb girdle muscular dystrophy 2I","volume":"186","author":"Thomas","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2022.08.009_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nmd.2006.12.004","article-title":"Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism","volume":"17","author":"Xu","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2022.08.009_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2353\/ajpath.2007.060927","article-title":"Overexpression of the cytotoxic T\u00a0cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A","volume":"171","author":"Xu","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2022.08.009_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2353\/ajpath.2009.080967","article-title":"Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice","volume":"175","author":"Xu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2022.08.009_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtm.2018.06.002","article-title":"An isolated limb infusion method allows for Broad distribution of rAAVrh74.MCK.GALGT2 to\u00a0leg\u00a0skeletal muscles in the rhesus macaque","volume":"10","author":"Xu","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.08.009_bib18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ymthe.2019.01.005","article-title":"rAAVrh74.MCK.GALGT2 Protects against loss of hemodynamic function in the aging mdx mouse heart","volume":"27","author":"Xu","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.08.009_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0896-6273(91)90301-F","article-title":"Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle","volume":"7","author":"Ohlendieck","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2022.08.009_bib20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0896-6273(91)90177-2","article-title":"Structure and expression of a rat agrin","volume":"6","author":"Rupp","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2022.08.009_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.200604179","article-title":"Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan","volume":"176","author":"Rezniczek","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2022.08.009_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0012-1606(84)90333-6","article-title":"Development of basal lamina in synaptic and extrasynaptic portions of embryonic rat muscle","volume":"103","author":"Chiu","year":"1984","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtm.2022.08.009_bib23","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1083\/jcb.139.6.1507","article-title":"Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice","volume":"139","author":"Patton","year":"1997","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2022.08.009_bib24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0896-6273(93)90152-H","article-title":"Developmental regulation of highly active alternatively spliced forms of agrin","volume":"11","author":"Hoch","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2022.08.009_bib25","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.ajpath.2015.06.008","article-title":"Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice","volume":"185","author":"Xu","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2022.08.009_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/mt.2013.246","article-title":"Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin alpha2 surrogates","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.08.009_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/dbio.2001.0530","article-title":"Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression","volume":"242","author":"Xia","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtm.2022.08.009_bib28","doi-asserted-by":"crossref","first-page":"e0248721","DOI":"10.1371\/journal.pone.0248721","article-title":"Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength","volume":"16","author":"Martin","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2022.08.009_bib29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.22251","article-title":"Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D","volume":"68","author":"Mendell","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2022.08.009_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.omtm.2019.10.005","article-title":"rAAVrh74.MCK.GALGT2 Demonstrates safety and Widespread muscle glycosylation after intravenous delivery in C57BL\/6J mice","volume":"15","author":"Zygmunt","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.08.009_bib31","series-title":"Corticosteroids for the Treatment of Duchenne Muscular Dystrophy","first-page":"CD003725","author":"Matthews","year":"2016"},{"key":"10.1016\/j.omtm.2022.08.009_bib32","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-0929","article-title":"Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy","volume":"127","author":"McMillan","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2022.08.009_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/bj20021892","volume":"373","author":"Montiel","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtm.2022.08.009_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0169-328X(02)00551-X","article-title":"Definition of pre- and postsynaptic forms of the CT carbohydrate antigen at the neuromuscular junction: ubiquitous expression of the CT antigens and the CT GalNAc transferase in mouse tissues","volume":"109","author":"Hoyte","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.omtm.2022.08.009_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mcne.1999.0737","article-title":"Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction","volume":"13","author":"Martin","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2022.08.009_bib36","first-page":"149","article-title":"The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials","volume":"87","author":"Ricotti","year":"2016","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.omtm.2022.08.009_bib37","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1089\/hum.2019.006","article-title":"Gene delivery for limb-girdle muscular dystrophy type 2D by isolated limb infusion","volume":"30","author":"Mendell","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.08.009_bib38","doi-asserted-by":"crossref","first-page":"e12785","DOI":"10.1111\/nan.12785","article-title":"Automated immunofluorescence analysis for sensitive and precise dystrophin\u00a0quantification in muscle biopsies","volume":"48","author":"Vetter","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012200119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012200119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:31:17Z","timestamp":1762421477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905012200119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":38,"alternative-id":["S232905012200119X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2022.08.009","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A first-in-human phase I\/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2022.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}]}}